Lonza Ltd. (Switzerland)

Pharmaceuticals
Switzerland
Earnings Per Share Growth (%)15.35%
Cost of Goods Sold (US$ Millions)$2,723
Current Liabilities (US$ Millions)$1,587
Total Assets (US$ Millions)$1,857
Long Term Debt$1,424
Return on Equity13.00%
Revenue (US$ Millions)$3,829
Total Company Assets$6,291
Revenue Growth (%)4.48%
Net Income (US$ Millions)$279
Earnings Per Share (US$)$15.35
Total Equity (US$ Millions)$2,150
Profit Margin (%)7.28%
Debt To Equity Ratio (%)0.66%
Inventory Turnover$899